Physician

Jonathan Andrew Jensen, M.D.

According to 2025 Medicare claims, Jonathan Jensen, M.D. (NPI: 1760825137) practices urology in the Wichita, KS market, with the plurality of this provider's patient population coming from Sedgwick, KS. This provider's primary affiliated billing organization is WICHITA UROLOGY GROUP P.A. (NPI: 1639157498; TIN: 481253013) and primary practice location at 67226-8110. Jensen is affiliated with the Aledade 155 National MSSP (ACO ID: A5358) and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Jensen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,379 traditional Medicare patients, billed 24,762 HCPCS/CPT codes, and received $560,894 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,197 prescription claims across 524 beneficiaries totaling $1,929,104 in drug costs, led by Erleada (Apalutamide). DME data shows 68 claims. Open Payments data shows 14 records totaling $495. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $171,249 and ending at $560,894. Concurrently, Part D prescription costs have risen steadily, from $1,698 to $1,929,104. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	567	10,628	$171,249
2020	1,023	25,432	$468,755
2021	1,334	25,611	$568,852
2022	1,411	19,630	$346,331
2023	1,444	22,471	$359,357
2024	1,379	24,762	$560,894

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	32	$1,698
2016	93	176	$2,123
2017	38	58	$773
2018	38	62	$463
2019	96	151	$77,881
2020	302	1,030	$368,175
2021	401	1,421	$363,666
2022	438	1,703	$550,714
2023	434	1,745	$1,812,321
2024	524	2,197	$1,929,104

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	11	57	$32,704
2021	11	75	$45,099
2022	12	62	$65,218
2023	12	85	$90,089
2024	12	68	$87,992

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	280	345	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	458	554	$57
84153	Psa (prostate specific antigen) measurement, total	257	266	$18
36415	Insertion of needle into vein for collection of blood sample	317	331	$9
51798	Ultrasound measurement of bladder capacity after voiding	258	306	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	51	1,530	$733,535
Nubeqa	Darolutamide	33	990	$408,485
Xtandi	Enzalutamide	22	660	$318,038
Orgovyx	Relugolix	106	3,178	$279,274
Myrbetriq	Mirabegron	43	1,507	$23,052

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	18	$55,206
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	12	38	$19,483
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	12	$13,303

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$495	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jonathan Andrew Jensen, M.D.?

Tedicare shows public-source Medicare data for Jonathan Andrew Jensen, M.D. (NPI 1760825137), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Andrew Jensen, M.D. have ACO affiliation data?

Jonathan Andrew Jensen, M.D. is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358) and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Jonathan Andrew Jensen, M.D.?

Jonathan Andrew Jensen, M.D. is linked to WICHITA UROLOGY GROUP P.A. (billing NPI 1639157498) in the available physician profile data.

Does Jonathan Andrew Jensen, M.D. have Open Payments data?

Jonathan Andrew Jensen, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.